Wheaton Offers Unique Solutions for the Clinical Market
|
By LabMedica International staff writers Posted on 29 Jul 2014 |
|
Wheaton (Millville, NJ, USA) provides high performance specialty containers to scientists and drug developers. The company is expanding its solutions-oriented product line to address the specific needs of the clinical laboratory. Clinical lab products that will be featured at AACC 2014 include vials specially designed for the cryopreservation of tissue samples, high precision chromatography vials, and vials eliminating 99% of residual waste for high value reagents.
CryoElite tissue vials are designed for the safe, secure, and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers and clinicians a uniform vial that maintains sample integrity while maximizing storage capacity and organization. They were developed for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations, and biorepository and biobanking facilities.
MicroLiter chromatography vials are Class 10,000 clean room packed, making them a good choice for clinical Limit of Detection (LOD)/Limit of Quantitation (LOQ) assays, limited quantity specimens and unknown targets. They offer and high precision, versatility, and are easy-to-use. They were designed to the tightest tolerances to ensure that they exceed all autosampler specifications. The MicroLiter MPSS allows for robotic liquid handling with the “uLmat” that eliminates leakage and cross contamination between wells.
The line of high recovery vials has a special interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
Related Links:
Wheaton
 assay.jpg)
CryoElite tissue vials are designed for the safe, secure, and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers and clinicians a uniform vial that maintains sample integrity while maximizing storage capacity and organization. They were developed for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations, and biorepository and biobanking facilities.
MicroLiter chromatography vials are Class 10,000 clean room packed, making them a good choice for clinical Limit of Detection (LOD)/Limit of Quantitation (LOQ) assays, limited quantity specimens and unknown targets. They offer and high precision, versatility, and are easy-to-use. They were designed to the tightest tolerances to ensure that they exceed all autosampler specifications. The MicroLiter MPSS allows for robotic liquid handling with the “uLmat” that eliminates leakage and cross contamination between wells.
The line of high recovery vials has a special interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
Related Links:
Wheaton
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Latest AACC 2014 News
- Corgenix Diagnostic Ebola Test Research Earns Abstract Award
- Atomo's Blood Test Unveiled at 2014 AACC; Takes Top Award in NY
- Roche Partners with Customers, Redefines Laboratory Value
- Abbott Showcases Innovations, Helps Labs Solve Health Care Challenges
- Sony DADC BioSciences and TSMC Receive AACC Award
- Oncolab Exhibits Pioneering AMAS Cancer Test at AACC
- Thermo Fisher Scientific Showcases Expanded Offering for Clinical Laboratory
- Major Advances in Medical Studies Highlighted at AACC 2014
- Seegene Reveals New Real-Time PCR at AACC 2014
- AACC Debuts Refreshed Brand Identity
- Mobile Health, Big Data, Antimicrobial Resistance Central to 2014 Meeting
- EKF Highlights Growing Product Portfolio at AACC 2014 Meeting
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Microbiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more
Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
